4eb2afdc 0def 430b Bb39 C7a7d2d4849a 01
Pentamidine Isethionate Injection, Powder, Lyophilized, For Solution
Product Images NDC 23155-748
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pentamidine Isethionate (NDC 23155-748). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
4eb2afdc 0def 430b Bb39 C7a7d2d4849a 02
4eb2afdc 0def 430b Bb39 C7a7d2d4849a 03
This is a non-pyrogenic, sterile, and preservative-free lyophilized drug named Pentamidine Isethionate for intramuscular or intravenous use. Each single-dose vial contains 300mg/vi of Pentamidine Isethionate. The manufacturer suggests reconstituting the vial content with sterile water for injection or 5% dextrose injection. The usual dosage for this drug is mentioned in the package insert. The storage temperature for the dry product is mentioned as 20° to 25°C. Protection from light is also recommendable for dry products and the reconstituted solution. The manufacturing license is numbered MB/13/859, and the drug is produced by Immacule Lifesciences Private Limited, India, for Avet Pharmaceuticals Inc., New Jersey. The expiration date is not available in the given text.*
4eb2afdc 0def 430b Bb39 C7a7d2d4849a 04
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
